Federal Register / Vol. 87, No. 126 / Friday, July 1, 2022 / Notices 39537 

the meeting at https://www.hhs.gov/ 

ohrp/sachrp-committee/meetings/ 

index.html. 

FOR FURTHER INFORMATION CONTACT: Julia 

Gorey, J.D., Executive Director, 

SACHRP; U.S. Department of Health 

and Human Services, 1101 Wootton 

Parkway, Suite 200, Rockville, 

Maryland 20852; telephone: 240–453– 

8141; fax: 240–453–6909; email address: 

SACHRP@hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

authority of 42 U.S.C. 217a, Section 222 

of the Public Health Service Act, as 

amended, SACHRP was established to 

provide expert advice and 

recommendations to the Secretary of 

Health and Human Services, through 

the Assistant Secretary for Health, on 

issues and topics pertaining to or 

associated with the protection of human 

research subjects. 

The Subpart A Subcommittee (SAS) 

was established by SACHRP in October 

2006 and is charged with developing 

recommendations for consideration by 

SACHRP regarding the application of 

subpart A of 45 CFR part 46 in the 

current research environment. 

The Subcommittee on Harmonization 

(SOH) was established by SACHRP at its 

July 2009 meeting and charged with 

identifying and prioritizing areas in 

which regulations and/or guidelines for 

human subjects research adopted by 

various agencies or offices within HHS 

would benefit from harmonization, 

consistency, clarity, simplification 

and/or coordination. 

The SACHRP meeting will open to the 

public at 9:00 a.m., on Wednesday, July 

20, 2022, followed by opening remarks 

from Dr. Jerry Menikoff, Director of 

OHRP and Dr. Douglas Diekema, 

SACHRP Chair. The meeting will begin 

with a discussion of the impact of social 

media use by research subjects; this will 

be followed by a final review of draft 

recommendations on the ethical and 

regulatory considerations for the use of 

artificial intelligence in human subjects 

research, and commentary on the 

Request for Public Comments on 

DRAFT Supplemental Information to 

the NIH Policy for Data Management 

and Sharing: Protecting Privacy When 

Sharing Human Research Participant 

Data. The second day, Thursday, July 

21st, will include consideration of the 

current HHS policy of engagement and 

the interpretation of HHS support in 45 

CFR 46, the OHRP Draft Guidance on 

Use of a Single Institutional Review 

Board for Cooperative Research 

(anticipated to have been released by 

the time of this publication), and may 

continue discussion of topics from the 

first day’s agenda. Other topics may be 

added; for the full and updated meeting 

agenda, see http://www.dhhs.gov/ohrp/ 

sachrp-committee/meetings/index.html. 

The meeting will adjourn by 4:00 p.m. 

July 21st, 2022. 

The public may submit written public 

comment in advance. Individuals 

submitting written statements as public 

comment should submit their comments 

to SACHRP at SACHRP@hhs.gov by 

midnight July 15th, 2022, ET. 

Comments are limited to three minutes 

each. 

Time will be allotted for public 

comment on both days. Note that public 

comment must be relevant to topics 

currently being addressed by the 

SACHRP. 

Dated: June 6, 2022. 

Julia G. Gorey, 

Executive Director, SACHRP, Office for 

Human Research Protections. 

[FR Doc. 2022–14102 Filed 6–30–22; 8:45 am] 

BILLING CODE 4150–36–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Implementation 

Grant on Liver Transplantation. 

Date: August 8, 2022. 

Time: 9:30 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NIH–NIDDK, 6707 Democracy Blvd., 

Room 7017, Bethesda, MD 20817 (Virtual 

Meeting). 

Contact Person: Maria E. Davila-Bloom, 

Ph.D., Scientific Review Officer, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 7017, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–7637, davila-bloomm@

extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: June 28, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–14131 Filed 6–30–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Special 

Topics in Aging: Immune Response, Juvenile 

Protection Factors, Neuromuscular Function, 

and Environmental Exposure Impact on 

Alzheimer’s Disease. 

Date: July 25, 2022. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Samuel C. Edwards, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5210, 

MSC 7846, Bethesda, MD 20892, (301) 435– 

1246, edwardss@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Myalgic 

Encephalomyelitis-Chronic Fatigue 

Syndrome. 

Date: August 1, 2022. 

Time: 1:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: M. Catherine Bennett, 

Ph.D., Scientific Review Officer, Center for 


khammond on DSKJM1Z7X2PROD with NOTICES